Positive Partial 12-Week Blood Sugar Results from Lexaria’s GLP-1 Diabetes Animal Study
DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing blood sugar groups KELOWNA, BC / ...
T-Net7d
Kelowna-based Lexaria Closes $5 Million Financing via Private Placement (Registered Direct Offering)
Bioscience Corp. (Nasdaq:LEXX; LEXXW), a developer of drug delivery platforms, today announced that it has closed a ...
Nasdaq9d
Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
KELOWNA, BC / ACCESSWIRE / October 15, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that ...
Investing2d
Lexaria reports advances in weight loss drug study
KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX) has announced partial final results from its WEIGHT-A24-1 animal study, showing positive outcomes for its DehydraTECH-liraglutide and certain ...
Nasdaq15d
Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing
KELOWNA, BC / ACCESSWIRE / October 9, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce ...
Benzinga.com19d
Lexaria Bioscience (NASDAQ:LEXX) Stock Quotes, Forecast and News Summary
Lexaria Bioscience shares are trading lower by 6.5% Thursday morning. The company finalized agreements for a registered direct offering.
Positive Partial 12-Week Body Weight Results from Lexaria’s GLP-1 Diabetes Animal Study
DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing weight loss groups Accelerated rates ...
Investing2d
Lexaria reports advances in weight loss drug study
KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX) has announced partial final results from its WEIGHT-A24-1 animal study, showing positive outcomes for its DehydraTECH-liraglutide and certain ...
Morningstar2d
Positive Partial 12-Week Body Weight Results from Lexaria’s GLP-1 Diabetes Animal Study
Groups G and H used pure GLP-1 drugs (semaglutide and liraglutide respectively) in DehydraTECH compositions Recalculations led to slight changes from earlier reported data Lexaria is strongly ...
Stockhouse2d
Positive Partial 12-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study
Groups G and H used pure GLP-1 drugs (semaglutide and liraglutide respectively) in DehydraTECH compositions - Recalculations led to slight changes from earlier reported data Lexaria is strongly ...